All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited.
Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication.
The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
We will attend the International Conference On Nanomedicine And Nanobiotechnology (ICONAN 2017) that will be held in Barcelona, Spain, 25–27 September 2017, representing our open access journals at the interface of nanotechnology, medicine and biology:
Journal of Functional Biomaterials
Journal of Personalized Medicine
Please stop by our booth to chat with our delegates about our journals. They will answer any questions about open access publishing and our journals. We look forward to meeting you in Barcelona!
For more information on the conference, please visit: